Product Categories
Country: | China |
---|---|
Tel: | |
Mobile: | 17320513646 |
E-mail: | mike@molcoo.com |
QQ: | 3001071511 |
Skype: | Chat Now! |
Address: | Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China |
1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability.
2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs.
3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects.
4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes.
5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.
|
Product Name | MF | CAS | Details |
---|
Bumetanide Impurity | C7H5Cl2NO4S | 62971-57-7 | Details |
Methyl Arachidate | C21H42O2 | 1120-28-1 | Details |
Vildagliptin Impurity | C7H10N2O | 700376-84-7 | Details |
Granisetron Impurity | C17H22N4O | 160177-67-3 | Details |
Bisoprolol Impurity | C19H33NO5 | 1215342-36-1 | Details |
Ceftaroline Impurity | C22H20N8O5S4 | 953037-71-3 | Details |
Bisoprolol Impurity | C17H29NO4 | 1346601-75-9 | Details |
Budesonide | C25H34O6 | 51333-22-3 | Details |
Glucosamine sulphate Impurity | C8H15NO6 | 7512-17-6 | Details |
isopropyl 4-methylbenzenesulfonate | C10H14O3S | 2307-69-9 | Details |
Baricitinib Impurity | C8H12N2O2S | 2101302-47-8 | Details |
Mepivacaine Impurity | C6H10N2O3 | 4515-18-8 | Details |
Bortezomib Impurity | C19H25BN4O4 | 1132709-14-8 | Details |
Rasagiline Impurity | C15H11NO2 | 2142-01-0 | Details |
Methyl tricosanoate | C24H48O2 | 2433-97-8 | Details |
Levamlodipine Besylate | C26H31ClN2O8S | 150566-71-5 | Details |
Glucosamine sulphate Impurity | C12H20N2O8 | 13185-73-4 | Details |
Mepivacaine Impurity | C6H10N2O3 | 65445-62-7 | Details |
Vonoprazan Impurity | 2932441-73-9 | Details |
Imrecoxib Impurity | C9H12O4S | 1507299-93-5 | Details |
Rasagiline Impurity | C6H7N | 6921-28-4 | Details |
Fluticasone Propionate Impurity | C21H26F2O4S | 80473-92-3 | Details |
Minocycline Impurity | C23H28N4O6 | 864073-42-7 | Details |
Flurbiprofen Impurity | C13H9FO2 | 137045-30-8 | Details |
Apremilast Impurity | C12H16O4S | 1831833-38-5 | Details |
Dapagliflozin Impurity | C23H27ClO7 | 1632287-34-3 | Details |
Atracurium Impurity | C29H42NO7+ | 1100676-15-0 | Details |
Granisetron Impurity | C9H8N2O2 | 50890-83-0 | Details |
Isavuconazole Impurity | C13 H12 F2 N4 O | 1966991-73-0 | Details |
5-O-METHYLVISAMMINOL | C16H18O5 | 80681-42-1 | Details |
Minocycline EP Impurity I | C21H23N3O7 | 5874-95-3 | Details |
Acetylcysteine Impurity | C8H14N2O5S2 | 25779-79-7 | Details |
Cycloserine Impurity | C6H12N4O4 | 16337-02-3 | Details |
Bortezomib Impurity | C19H24N4O3 | 289472-78-2 | Details |
Bortezomib Impurity | C19H24N4O2 | 1446194-56-4 | Details |
Empagliflozin Impurity | C6H10O6 | 52153-09-0 | Details |
Tedizolid Impurity | C14H12N10 | 2095840-91-6 | Details |
Rasagiline Impurity | C12H14ClN | 1179031-47-0 | Details |
Mosapride Impurity | C21H25ClFN3O3 | 112886-58-5 | Details |
Darolutamide Impurity | C19H19ClN6O2 | 2407645-49-0 | Details |
Vildagliptin carboxylic acid Impurity | C17H26N2O4 | 565453-40-9 | Details |
2-Chloroethyl 3-oxobutanoate | C6H9ClO3 | 54527-68-3 | Details |
Granisetron Impurity | C9H9N3O | 129137-93-5 | Details |
Nicorandil Impurity(Dihydrochloride) | C8H11ClN2O2 | 87330-70-9 | Details |
Pitavastatin (3S,5S)-Isomer Calcium | C25H26CaFNO4 | 254452-92-1 | Details |
Darolutamide Impurity | C13H13ClN4 | 1297537-41-7 | Details |
Formic hydrazide | CH4N2O | 624-84-0 | Details |
Cinacalcet Impurity | C22H23ClF3N | 2469242-96-2 | Details |
Campathecin Impurity | C21H18N2O5 | 19685-10-0 | Details |
Bisoprolol Impurity | C13H21NO3 | 62572-93-4 | Details |
Azithromycin Impurity | C37H70N2O12 | 172617-84-4 | Details |
Alogliptin Impurity | C13H10ClN3O2 | 865758-96-9 | Details |
Empagliflozin | C23H27ClO7 | 864070-44-0 | Details |
Methyl linolenate | C19H32O2 | 301-00-8 | Details |
Rasagiline Impurity | C15H15N | 92850-02-7 | Details |
Metaraminol bitartrate Impurity | C9H10O3 | 639070-81-8 | Details |
Granisetron Impurity | C18H24N4O | 127472-42-8 | Details |
Celecoxib Impurity | C9H10O | 122-00-9 | Details |
Rilpivirine hydrochloride | C22H19ClN6 | 700361-47-3 | Details |
Bortezomib Impurity | C14H14N4O2 | 289472-80-6 | Details |
Budesonide Impurity | C23H28O5 | 4380-55-6 | Details |
Pitavastatin Impurity | C25H24FNO4 | 254452-96-5 | Details |
Atracurium Impurity | C21H27NO4 | 85-63-2 | Details |
Dapagliflozin Impurity | C21H27ClO7 | 1938090-31-3 | Details |
Methyl stearate | C19H38O2 | 112-61-8 | Details |
Mosapride Impurity | C21H25ClFN3O3 | 112886-56-3 | Details |
Thymol | C10H14O | 89-83-8 | Details |
Tenofovir Impurity | C4H7ClO3 | 35179-98-7 | Details |
Celecoxib Impurity | C17H14F3N3O3S | 170571-00-3 | Details |
ltrombopag Impurity | C13H11NO3 | 376592-93-7 | Details |
Olanzapine lactam Impurity | C17H20N4O2 | 1017241-34-7 | Details |
Budesonide Impurity | C24H32O6 | 192057-49-1 | Details |
LCZ696(valsartan + sacubitril)Sodium Impurity 2.5 Hydrate | C48H58N6O8 | 936623-90-4 | Details |
2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl isothiocyanate | C15H19NO9S | 14152-97-7 | Details |
Indapamide Impurity | C7H6ClNO4S | 1205-30-7 | Details |
Darolutamide Impurity | C6H8N2O3 | 1401584-94-8 | Details |
Methyl behenate | C23H46O2 | 929-77-1 | Details |
Palmitic Acid Methyl Ester[Methyl Palmitate] | C17H34O2 | 112-39-0 | Details |
Apremilast Impurity | C13H21NO5S | 2733250-84-3 | Details |
Ezetimibe Impurity | C30H37F2NO3Si2 | 272778-13-9 | Details |
Rosuvastatin Methyl Intermediate Impurity | C26H34FN3O6S | 851440-19-2 | Details |
Ceftaroline Impurity | C9H8N2S2 | 1427207-46-2 | Details |
Lurasidone Impurity | C28H36N4O3S | 1574569-32-6 | Details |
Revefenacin Impurity | C12H21N3O2 | 886508-20-9 | Details |
Granisetron Impurity | C17 H22 N4 O | 107007-95-4 | Details |
Budesonide Impurity | C23H26O4 | 37413-91-5 | Details |
Minocycline EP Impurity D | C21H23N3O7 | 5679-00-5 | Details |
Valsartan USP Related Compound A | C24H29N5O3 | 137862-87-4 | Details |
Ceftaroline Impurity | C22H22N8O8PS4.C2H3O2.H2O | 400827-55-6 | Details |
Ceftaroline Impurity | C22H23N8O9PS4 | 1286218-63-0 | Details |
Ceftaroline Impurity | C24H22N8O6S4 | 1240196-56-8 | Details |
Minocycline Impurity | C23H25N3O7 | 1346598-44-4 | Details |
Atracurium Impurity | C24H32NO6+ | 1075727-04-6 | Details |
Pyrantel pamoate | C34H30N2O6S | 22204-24-6 | Details |
Nicotinic Acid Impurity | C6H4N2O4 | 2047-49-6 | Details |
Celecoxib Impurity | C17H14F3N3O3S | 2356153-95-0 | Details |
Nafamostat Mesylate | C21H25N5O8S2 | 82956-11-4 | Details |
Ilaprazole Impurity | 2285346-38-3 | Details |
Formamide | CH3NO | 75-12-7 | Details |
Alectinib Impurity | C30H34N4O3 | 1256585-28-0 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 |